Treatment of recurrent germ cell tumors

Seminars in Surgical Oncology

Volumn 17, Issue 4, 1999, Pages 268-274

  Nichols, Craig R ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Autologous transplantation; Bone marrow transplantation; Brain neoplasms secondary; Carboplatin; Chorionic gonadotropins; Cisplatin; Combined antineoplastic agents; Combined modality therapy; Differential diagnosis; Dise ase free survival; Drug administration schedule; Etoposide; Gemcitabine; Germ cell and embryonic neoplasms; Ifosfamide; Lymph node excision; Neoplasm drug resistance; Neoplasm metastasis; Paclitaxel; Patient selection; Phase I clinical trials; Phase II clinical trials; Prognosis; Remission induction; Retroperitoneal neoplasms; Risk factors; Salvage therapy; Teratoma; Testicular neoplasms; Treatment outcome

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; IFOSFAMIDE; VINBLASTINE;

BONE MARROW SUPPRESSION; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL TRIAL; DRUG EFFICACY; GERM CELL TUMOR; GRANULOCYTOPENIA; HUMAN; KIDNEY FAILURE; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; REVIEW; SALVAGE THERAPY; TREATMENT OUTCOME;

EID: 0032787363     PISSN: 87560437     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2388(199912)17:4<268::AID-SSU8>3.0.CO;2-P     Document Type: Review

References (30)

1. Einhorn LH: Treatment of testicular cancer: a new and improved model. J Clin Oncol 1990;8:1777-1781.
2. Logothetis CJ, Samuels ML Trinidade A, Johnson DE: The growing teratoma syndrome. Cancer 1982;50:1629-1635.
3. Zon RT, Nichols C, Einhorn LH: Management strategies and outcomes of germ cell tumor patients with very high human chorionic gonadotropin levels. J Clin Oncol 1998;16:1294-1297.
4. Motzer RJ, Bajorin DF, Schwartz LH, et al: Phase II trial of paclitaxel shows antitumor activity in patients with previously treated germ cell tumors. J Clin Oncol 1994;12:2277-2283.
5. Loehrer PJ Jr, Gonin R, Nichols CR, et al: Vinblastine plus ifosfamide plus cisplatin as initial salvage therapy in recurrent germ cell tumors. J Clin Oncol 1998;16:2500-2504.
6. Motzer R, Cooper K, Geller NL, et al: The role of ifosfamide plus cisplatin-based chemotherapy as salvage therapy for patients with refractory germ cell tumors. Cancer 1990;66:2476-2481.
7. Nichols CR, Tricot G, Williams SD, et al: Dose-intensive chemotherapy in refractory germ cell cancer - a phase I/II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation. J Clin Oncol 1989;7:932-939.
8. Nichols CR, Breeden ES, Loehrer PJ, et al: Secondary leukemia associated with a conventional dose of etoposide: review of serial germ cell tumor protocols. J Natl Cancer Inst 1993;85:36-40.
9. Broun ER, Nichols CR, Kneebone P, et al: Long-term outcome of patients with relapsed and refractory germ cell tumors treated with high-dose chemotherapy and autologous bone marrow rescue. Ann Int Med 1992;117:124-128.
10. Nichols CR, Anderson J, Lazarus HM, et al: High-dose carboplatin and etoposide with autologous bone marrow transplantation in refractory germ cell cancer: an Eastern Cooperative Oncology Group protocol. J Clin Oncol 1992;10:558-563.
11. Broun ER, Nichols CR, Einhorn LH, et al: Salvage therapy with high-dose chemotherapy and autologous bone marrow support in the treatment of primary nonseminomatous mediastinal germ cell tumors. Cancer 1991;68:1513-1515.
12. Munshi NC, Loehrer PJ, Willaims SD, et al: Ifosfamide combination salvage chemotherapy in extragonadal germ cell tumors (EGGCT) [Abstract]. Proc Am Soc Clin Oncol 1991;10:182.
13. Wheeler BM, Loehrer PJ, Williams SD, Einhorn LH: Ifosfamide in refractory male germ cell tumors. J Clin Oncol 1986;4:28-34.
14. Broun ER, Nichols CR, Tricot G, et al: High dose carboplatin/VP-16 plus ifosfamide with autologous bone marrow support in the treatment of refractory germ cell tumors. Bone Marrow Transplant 1991;7:53-56.
15. Broun ER, Nichols CR, Mandanas R, et al: Dose escalation study of high-dose carboplatin and etoposide with autologous bone marrow support in patients with recurrent and refractory germ cell tumors. Bone Marrow Transplant 1995;16:353-358.
16. Beyer J, Kramar A, Mandanas R, et al: High-dose chemotherapy (HDCT) as salvage treatment in germ cell tumors (GCT): a multivariate analysis of prognostic variables [Abstract]. Proc Am Soc Clin Oncol 1996;15:239.
17. Motzer RJ, Gulati SC, Crown JP, et al: High-dose chemotherapy and autologous bone marrow rescue for patients with refractory germ cell tumors. Early intervention is better tolerated. Cancer 1992;69:550-556.
18. Linkesch W, Krainer M, Wagner A: Phase I/II trial of ultrahigh carboplatin, etoposide, cyclophosphamide with ABMT in refractory or relapsed non-seminomatous germ cell tumors (NSGCT) [Abstract]. Proc Am Soc Clin Oncol 1992;11:196.
19. Siegert W, Beyer J, Strohscheer I, et al: High-dose treatment with carboplatin, etoposide, and ifosfamide followed by autologous stem-cell transplantation in relapsed or refractory germ cell cancer: a phase I/II study. The German Testicular Cancer Cooperative Study Group. J Clin Oncol 1994;12:1223-1231.
20. Barnett MJ, Coppin CM, Murray N, et al: High-dose chemotherapy and autologous bone marrow transplantation for patients with poor prognosis nonseminomatous germ cell tumors. Br J Cancer 1993;68:594-598.
21. Bhatia S, Cornetta K, Broun R, et al: High dose chemotherapy with peripheral stem cell or autologous bone marrow transplant as initial salvage chemotherapy for testicular cancer [Abstract]. Proc Am Soc Clin Oncol 1998;17:321A, #1239.
22. Murphy BR, Breeden ES, Donohue JP, et al: Surgical salvage of chemorefractory germ cell tumors. J Clin Oncol 1993;11:324-329.
23. Bokemeyer C, Beyer J, Metzner B, et al: Phase II study of paclitaxel in patients with relapsed or cisplatin-refractory testicular cancer. Ann Oncol 1996:7:31-34.
24. Sandler AB, Cristou A, Fox S, et al: A phase II trial of paclitaxel in refractory germ cell tumors. Cancer 1998;82:1381-1386.
25. Bokemeyer C, Gerl A, Schoffski P, et al: Gemcitabine in patients with relapsed or cisplatin-refractory testicular cancer. J Clin Oncol 1999;17:512-516.
26. Einhorn LH, Stender MJ, Williams SD: Phase II trial of gemcitabine in refractory germ cell tumors. J Clin Oncol 1999;17:509-511.
27. Baniel J, Foster RS, Gonin R, et al: Late relapse of testicular cancer. J Clin Oncol 1995;13:1170-1176.
28. Gerl A, Clemm C, Schmeller N, et al: Late relapse of germ cell tumors after cisplatin-based chemotherapy [Review]. Ann Oncol 1997;8:41-47.
29. nd, Lester SG, et al: Brain metastases and testicular tumors: long-term survival. Int J Radiat Oncol Biol Phys 1992;22:17-22.
30. Fossa SD, Bokemeyer C, Gerl A, et al: Treatment outcome of patients with brain metastases from malignant germ cell tumors. Cancer 1999;85:988-997.